Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03188094 · ClinicalTrials.gov registry record · NA

Integrated Community-Clinical Linkage Model to Promote Weight Loss Among South Asians With Pre-Diabetes

A NA study of Weight Loss and Pre Diabetes, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
974
Enrollment target
1
Study location

NCT03188094 is a NA study of Weight Loss and Pre Diabetes that has completed, run by NYU Langone Health. The registered enrollment target is 974 participants, below the 1,493-participant average among 116 other Weight Loss trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03188094, a NA study of Weight Loss and Pre Diabetes, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
974 participants
Enrollment target
1
Study location

Study Summary

The proposed study will inform efforts to prevent diabetes and promote weight loss in a high-risk population and generate a reproducible, scalable, and sustainable model for use with other insurer groups and clinical settings that work in immigrant populations with a high burden of chronic disease.

Conditions Studied

Interventions

  • BEHAVIORAL CHW-Led Health Coaching
  • OTHER EHR Alerts

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 974 participants
Start Date 2018-12-17
Est. Completion 2024-06-30
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT03188094

The ClinicalTrials.gov registry entry for NCT03188094 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 974 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,493-participant average among 116 other Weight Loss trials with a reported enrollment target (35% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Weight Loss appearing as the primary indexed condition, and to 2 interventions - of which CHW-Led Health Coaching is the first listed.

NCT03188094 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03188094 about?

NCT03188094 is a clinical study titled "Integrated Community-Clinical Linkage Model to Promote Weight Loss Among South Asians With Pre-Diabetes". The proposed study will inform efforts to prevent diabetes and promote weight loss in a high-risk population and generate a reproducible, scalable, and sustainable model for use with other insurer groups and clinical settings that work in immigrant populations with a high burden of chronic disease.

What is the current status of trial NCT03188094?

This trial is currently completed. It is a NA study. The enrollment target is 974 participants. The study started on 2018-12-17. Estimated completion is 2024-06-30.

What conditions does trial NCT03188094 study?

This clinical trial studies the following conditions: Weight Loss, Pre Diabetes.

What interventions are being tested in trial NCT03188094?

The interventions under investigation include: CHW-Led Health Coaching (BEHAVIORAL), EHR Alerts (OTHER).

Who is sponsoring clinical trial NCT03188094?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03188094 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Weight Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.